CA2620740A1 - Pyridazinone derivatives used for the treatment of pain - Google Patents
Pyridazinone derivatives used for the treatment of pain Download PDFInfo
- Publication number
- CA2620740A1 CA2620740A1 CA002620740A CA2620740A CA2620740A1 CA 2620740 A1 CA2620740 A1 CA 2620740A1 CA 002620740 A CA002620740 A CA 002620740A CA 2620740 A CA2620740 A CA 2620740A CA 2620740 A1 CA2620740 A1 CA 2620740A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- hydrogen
- unsubstituted
- methylphenyl
- unsubstituted lower
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title description 49
- -1 pyridazinone derivative compound Chemical class 0.000 claims abstract description 315
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 106
- 239000001257 hydrogen Substances 0.000 claims abstract description 101
- 150000002431 hydrogen Chemical group 0.000 claims abstract description 57
- 150000003839 salts Chemical class 0.000 claims abstract description 52
- 125000003118 aryl group Chemical group 0.000 claims abstract description 42
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 8
- 239000001301 oxygen Substances 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 152
- 125000001424 substituent group Chemical group 0.000 claims description 76
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 48
- 150000001875 compounds Chemical class 0.000 claims description 44
- 229910052736 halogen Inorganic materials 0.000 claims description 44
- 150000002367 halogens Chemical class 0.000 claims description 44
- 125000002947 alkylene group Chemical group 0.000 claims description 40
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 39
- 125000003545 alkoxy group Chemical group 0.000 claims description 34
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 29
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 26
- 125000001589 carboacyl group Chemical group 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 21
- 125000004423 acyloxy group Chemical group 0.000 claims description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- 125000001118 alkylidene group Chemical group 0.000 claims description 16
- 125000005842 heteroatom Chemical group 0.000 claims description 16
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 12
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 11
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 9
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 8
- 150000001721 carbon Chemical group 0.000 claims description 8
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 125000001072 heteroaryl group Chemical group 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 208000011231 Crohn disease Diseases 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 6
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 6
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- 230000004054 inflammatory process Effects 0.000 claims description 6
- 125000005281 alkyl ureido group Chemical group 0.000 claims description 5
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 claims description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 14
- 125000004750 (C1-C6) alkylaminosulfonyl group Chemical group 0.000 claims 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 176
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 139
- 101150041968 CDC13 gene Proteins 0.000 description 136
- 239000000203 mixture Substances 0.000 description 112
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 85
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 84
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 74
- 238000002360 preparation method Methods 0.000 description 73
- 239000000243 solution Substances 0.000 description 70
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 52
- 229910052757 nitrogen Inorganic materials 0.000 description 52
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 37
- 229910001868 water Inorganic materials 0.000 description 37
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 34
- 235000019439 ethyl acetate Nutrition 0.000 description 34
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 33
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 33
- 239000012044 organic layer Substances 0.000 description 31
- 239000012267 brine Substances 0.000 description 28
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 28
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 28
- 239000011734 sodium Substances 0.000 description 26
- 239000007787 solid Substances 0.000 description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 235000017557 sodium bicarbonate Nutrition 0.000 description 22
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 22
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 18
- 235000019341 magnesium sulphate Nutrition 0.000 description 18
- 239000000725 suspension Substances 0.000 description 18
- 238000004440 column chromatography Methods 0.000 description 17
- 239000003480 eluent Substances 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 125000003944 tolyl group Chemical group 0.000 description 14
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 13
- VBXYJTRDAAYDCJ-SFHVURJKSA-N chembl2170284 Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC[C@@H](CO)NC3=2)C=2C=CC(F)=CC=2)=N1 VBXYJTRDAAYDCJ-SFHVURJKSA-N 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 13
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 12
- 238000010828 elution Methods 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 238000003818 flash chromatography Methods 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000007832 Na2SO4 Substances 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- 125000003282 alkyl amino group Chemical group 0.000 description 11
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 229910052938 sodium sulfate Inorganic materials 0.000 description 11
- 235000011152 sodium sulphate Nutrition 0.000 description 11
- KTPOXQVGTABKFF-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CO)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 KTPOXQVGTABKFF-UHFFFAOYSA-N 0.000 description 10
- 125000001153 fluoro group Chemical group F* 0.000 description 10
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 10
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 10
- KDWXNVQYEFVHPZ-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-6-[(dimethylamino)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1F KDWXNVQYEFVHPZ-UHFFFAOYSA-N 0.000 description 9
- LYHNSWOZRDSWLX-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CO)CNC3=2)C=2C=CC(F)=CC=2)=N1 LYHNSWOZRDSWLX-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 8
- 108090000695 Cytokines Proteins 0.000 description 8
- 102000004127 Cytokines Human genes 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 description 8
- 125000004430 oxygen atom Chemical group O* 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 102100040247 Tumor necrosis factor Human genes 0.000 description 7
- 125000005236 alkanoylamino group Chemical group 0.000 description 7
- 125000005115 alkyl carbamoyl group Chemical group 0.000 description 7
- 125000006310 cycloalkyl amino group Chemical group 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 229910052717 sulfur Inorganic materials 0.000 description 7
- 125000004434 sulfur atom Chemical group 0.000 description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 7
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 6
- RPPJHJYVSWATLF-UHFFFAOYSA-N 6-[2'-(4-fluorophenyl)spiro[1,3-dioxolane-2,6'-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine]-3'-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CNC3=2)OCCO4)C=2C=CC(F)=CC=2)=N1 RPPJHJYVSWATLF-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 101100291385 Drosophila melanogaster p38a gene Proteins 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 102000043136 MAP kinase family Human genes 0.000 description 6
- 108091054455 MAP kinase family Proteins 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 125000002393 azetidinyl group Chemical group 0.000 description 6
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 6
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 6
- VTXYBIGLJBVFOG-UHFFFAOYSA-N ethyl 3-(4-fluorophenyl)-2-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-3-oxopropanoate Chemical compound C1=CC(=O)N(C=2C(=CC=CC=2)C)N=C1C(C(=O)OCC)C(=O)C1=CC=C(F)C=C1 VTXYBIGLJBVFOG-UHFFFAOYSA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 235000015320 potassium carbonate Nutrition 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- XENIVCGPPCBEMP-UHFFFAOYSA-N 6-[1'-acetyl-2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-piperidine]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C1CN(C(=O)C)CCC21CN1N=C(C=3C=CC(F)=CC=3)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C1NC2 XENIVCGPPCBEMP-UHFFFAOYSA-N 0.000 description 5
- YJTHZVZNHQPGFS-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6,6-bis(hydroxymethyl)-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CO)(CO)CNC3=2)C=2C=CC(F)=CC=2)=N1 YJTHZVZNHQPGFS-UHFFFAOYSA-N 0.000 description 5
- QXYRMVUWXFWUKP-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(O)CNC3=2)C=2C=CC(F)=CC=2)=N1 QXYRMVUWXFWUKP-UHFFFAOYSA-N 0.000 description 5
- SXKMPLDBLZUHKW-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-oxane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCOCC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 SXKMPLDBLZUHKW-UHFFFAOYSA-N 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 5
- 125000002757 morpholinyl group Chemical group 0.000 description 5
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 4
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 4
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 4
- HKDFQYNSDGYSMQ-UHFFFAOYSA-N 6-[1-ethyl-6-(4-fluorophenyl)-2,3-dihydroimidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C=12N(CC)CCN2N=C(C=2C=CC(F)=CC=2)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C HKDFQYNSDGYSMQ-UHFFFAOYSA-N 0.000 description 4
- ZMRHRXJRKCSHEX-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-6-[(dimethylamino)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)-4,5-dihydropyridazin-3-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C=2CCC(=O)N(N=2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1F ZMRHRXJRKCSHEX-UHFFFAOYSA-N 0.000 description 4
- XULNXLJZCKTURE-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-6-[(dimethylamino)methyl]pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2C=C(CN(C)C)C=NC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1F XULNXLJZCKTURE-UHFFFAOYSA-N 0.000 description 4
- HZEJSHBOXAKPPP-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-[(4-methylpiperazin-1-yl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCN1CC1CN2N=C(C=3C=CC(F)=CC=3)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C2NC1 HZEJSHBOXAKPPP-UHFFFAOYSA-N 0.000 description 4
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 206010036030 Polyarthritis Diseases 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- QXYRMVUWXFWUKP-QGZVFWFLSA-N chembl2170292 Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@H](O)CNC3=2)C=2C=CC(F)=CC=2)=N1 QXYRMVUWXFWUKP-QGZVFWFLSA-N 0.000 description 4
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 4
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 4
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 4
- 210000000548 hind-foot Anatomy 0.000 description 4
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- FOQHPFUEEKPISH-UHFFFAOYSA-N 2-(6-chloropyridazin-3-yl)-1-(4-fluorophenyl)ethanone Chemical compound C1=CC(F)=CC=C1C(=O)CC1=CC=C(Cl)N=N1 FOQHPFUEEKPISH-UHFFFAOYSA-N 0.000 description 3
- AVLRPQBKZSYLED-UHFFFAOYSA-N 3-[6-(4-fluorophenyl)-7-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-2,3-dihydroimidazo[1,2-b]pyrazol-1-yl]propanoic acid Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCC(O)=O)CCN3N=C2C=2C=CC(F)=CC=2)=N1 AVLRPQBKZSYLED-UHFFFAOYSA-N 0.000 description 3
- XDHQIVYBPKRWMO-HKBQPEDESA-N 6-[(5S)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-(4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC[C@@H](CO[Si](C=4C=CC=CC=4)(C=4C=CC=CC=4)C(C)(C)C)NC3=2)C=2C=CC(F)=CC=2)=N1 XDHQIVYBPKRWMO-HKBQPEDESA-N 0.000 description 3
- JBAZSHKDGSLFQS-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-6-(methylaminomethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CNC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1F JBAZSHKDGSLFQS-UHFFFAOYSA-N 0.000 description 3
- LBEHXJNZFUBWGR-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-2-oxoethyl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(CC(=O)C=2C=CC(F)=CC=2)=N1 LBEHXJNZFUBWGR-UHFFFAOYSA-N 0.000 description 3
- JCGYGSHDCKRRGT-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-methylidene-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(=C)CNC3=2)C=2C=CC(F)=CC=2)=N1 JCGYGSHDCKRRGT-UHFFFAOYSA-N 0.000 description 3
- PXBBRPASPKYEGW-UHFFFAOYSA-N 6-[6-(diethylaminomethyl)-2-(2,4-difluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(CC)CC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1F PXBBRPASPKYEGW-UHFFFAOYSA-N 0.000 description 3
- CBHCUXNXILTYGU-UHFFFAOYSA-N 6-[6-(methylaminomethyl)-2-(3-methylphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CNC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=CC(C)=C1 CBHCUXNXILTYGU-UHFFFAOYSA-N 0.000 description 3
- ICLKJDINTLONMD-UHFFFAOYSA-N 6-[6-[(tert-butylamino)methyl]-2-(2,4-difluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC(C)(C)C)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 ICLKJDINTLONMD-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002198 insoluble material Substances 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229920006008 lipopolysaccharide Polymers 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 3
- 125000003107 substituted aryl group Chemical group 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- NSJVYHOPHZMZPN-UHFFFAOYSA-N (2-methylphenyl)boronic acid Chemical compound CC1=CC=CC=C1B(O)O NSJVYHOPHZMZPN-UHFFFAOYSA-N 0.000 description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- DFPYXQYWILNVAU-UHFFFAOYSA-N 1-hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1.C1=CC=C2N(O)N=NC2=C1 DFPYXQYWILNVAU-UHFFFAOYSA-N 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- QFIGPPXWHDUBDP-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carbonitrile Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C#N)C=2C(=CC(F)=CC=2)F)=N1 QFIGPPXWHDUBDP-UHFFFAOYSA-N 0.000 description 2
- LZVVWTLCWXRLPV-UHFFFAOYSA-N 2-(2,5-difluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carbonitrile Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C#N)C=2C(=CC=C(F)C=2)F)=N1 LZVVWTLCWXRLPV-UHFFFAOYSA-N 0.000 description 2
- QGHIBZYZAXKDJE-UHFFFAOYSA-N 2-(2-methylphenyl)-6-(2-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)pyridazin-3-one;hydrochloride Chemical compound Cl.CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CCNCC3=2)C=2C=CC=CC=2)=N1 QGHIBZYZAXKDJE-UHFFFAOYSA-N 0.000 description 2
- NWOYAXCJZOCPIP-UHFFFAOYSA-N 2-(2-methylphenyl)-6-(2-phenyl-5-propan-2-yl-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazin-3-yl)pyridazin-3-one Chemical compound C=12CN(C(C)C)CCN2N=C(C=2C=CC=CC=2)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C NWOYAXCJZOCPIP-UHFFFAOYSA-N 0.000 description 2
- NXCRRUWCPBGKJS-UHFFFAOYSA-N 2-(2-methylphenyl)-6-(2-phenylpyrazolo[1,5-a]pyrazin-3-yl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3C=NC=CN3N=C2C=2C=CC=CC=2)=N1 NXCRRUWCPBGKJS-UHFFFAOYSA-N 0.000 description 2
- RAXLOGSJMILTNQ-UHFFFAOYSA-N 2-(2-methylphenyl)-6-[2-(3-methylphenyl)-6-[(4-methylpiperazin-1-yl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]pyridazin-3-one Chemical compound C1CN(C)CCN1CC1CN2N=C(C=3C=C(C)C=CC=3)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C2NC1 RAXLOGSJMILTNQ-UHFFFAOYSA-N 0.000 description 2
- FBGRSCRCSCBXIC-UHFFFAOYSA-N 2-(3-methylphenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carbonitrile Chemical compound CC1=CC=CC(C=2C(=C3NCC(CN3N=2)C#N)C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)=C1 FBGRSCRCSCBXIC-UHFFFAOYSA-N 0.000 description 2
- OXYHRHVOWTXRHI-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carbaldehyde Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C=O)C=2C=CC(F)=CC=2)=N1 OXYHRHVOWTXRHI-UHFFFAOYSA-N 0.000 description 2
- NBZURRLWUUNAJK-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carbonitrile Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C#N)C=2C=CC(F)=CC=2)=N1 NBZURRLWUUNAJK-UHFFFAOYSA-N 0.000 description 2
- GLWBNRLPTYCDAL-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carboxylic acid Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C(O)=O)C=2C=CC(F)=CC=2)=N1 GLWBNRLPTYCDAL-UHFFFAOYSA-N 0.000 description 2
- JIYWTGQPSWMLDJ-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-6-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(=O)CNC3=2)C=2C=CC(F)=CC=2)=N1 JIYWTGQPSWMLDJ-UHFFFAOYSA-N 0.000 description 2
- KXYBVKOGKCSFFI-UHFFFAOYSA-N 3-[(dimethylamino)methyl]azetidine-1-carbothiohydrazide Chemical compound CN(C)CC1CN(C(=S)NN)C1 KXYBVKOGKCSFFI-UHFFFAOYSA-N 0.000 description 2
- MKYXDAZWQWYGQD-UHFFFAOYSA-N 3-[2-(2,4-difluorophenyl)-6-[(dimethylamino)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-1H-pyridazin-6-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C2=NNC(=O)C=C2)C=1C1=CC=C(F)C=C1F MKYXDAZWQWYGQD-UHFFFAOYSA-N 0.000 description 2
- GSGOGCKGCIAYLL-UHFFFAOYSA-N 3-[2-(4-fluorophenyl)-2-oxoethyl]-1h-pyridazin-6-one Chemical compound C1=CC(F)=CC=C1C(=O)CC1=NNC(=O)C=C1 GSGOGCKGCIAYLL-UHFFFAOYSA-N 0.000 description 2
- ZPNVNPQHWDNYKF-UHFFFAOYSA-N 3-[6-(4-fluorophenyl)-7-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-2,3-dihydroimidazo[1,2-b]pyrazol-1-yl]propyl methanesulfonate Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCCOS(C)(=O)=O)CCN3N=C2C=2C=CC(F)=CC=2)=N1 ZPNVNPQHWDNYKF-UHFFFAOYSA-N 0.000 description 2
- HLKONDFQQHNQJK-UHFFFAOYSA-N 3-[[2-(2,4-difluorophenyl)-1,3-dioxolan-2-yl]methyl]-1h-pyridazin-6-one Chemical compound FC1=CC(F)=CC=C1C1(CC2=NNC(=O)C=C2)OCCO1 HLKONDFQQHNQJK-UHFFFAOYSA-N 0.000 description 2
- AHARRJLATDBVBU-UHFFFAOYSA-N 3-[[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]methyl]-1h-pyridazin-6-one Chemical compound C1=CC(F)=CC=C1C1(CC2=NNC(=O)C=C2)OCCO1 AHARRJLATDBVBU-UHFFFAOYSA-N 0.000 description 2
- UQGCZJUCUGZCKD-DEOSSOPVSA-N 6-[(6S)-2-(4-fluorophenyl)-6-phenylmethoxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@H](CNC3=2)OCC=2C=CC=CC=2)C=2C=CC(F)=CC=2)=N1 UQGCZJUCUGZCKD-DEOSSOPVSA-N 0.000 description 2
- WXIZSONXZNJOLJ-UHFFFAOYSA-N 6-[1-bromo-2-(2,4-difluorophenyl)-2-oxoethyl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C(Br)C(=O)C=2C(=CC(F)=CC=2)F)=N1 WXIZSONXZNJOLJ-UHFFFAOYSA-N 0.000 description 2
- LYABFVJNJUUFLU-UHFFFAOYSA-N 6-[2-(2,5-difluorophenyl)-6-(methylaminomethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CNC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC(F)=CC=C1F LYABFVJNJUUFLU-UHFFFAOYSA-N 0.000 description 2
- AJWDBKBVQJJPFO-UHFFFAOYSA-N 6-[2-(2,5-difluorophenyl)-6-[(4-methylpiperazin-1-yl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C1CN(C)CCN1CC1CN2N=C(C=3C(=CC=C(F)C=3)F)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C2NC1 AJWDBKBVQJJPFO-UHFFFAOYSA-N 0.000 description 2
- TYGHLQQIWILSOC-UHFFFAOYSA-N 6-[2-(2-chloro-4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CO)CNC3=2)C=2C(=CC(F)=CC=2)Cl)=N1 TYGHLQQIWILSOC-UHFFFAOYSA-N 0.000 description 2
- QMBQWEIXZSRYPK-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-(hydroxyiminomethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C=NO)C=2C=CC(F)=CC=2)=N1 QMBQWEIXZSRYPK-UHFFFAOYSA-N 0.000 description 2
- XCQMBZGOWVHCLX-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-(iodomethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CI)CNC3=2)C=2C=CC(F)=CC=2)=N1 XCQMBZGOWVHCLX-UHFFFAOYSA-N 0.000 description 2
- UONVQNZKINLVAT-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-(methylaminomethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CNC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 UONVQNZKINLVAT-UHFFFAOYSA-N 0.000 description 2
- OETPHHYMNUPPFD-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-piperidine]-3-yl]-2-(2-methylphenyl)pyridazin-3-one hydrochloride Chemical compound Cl.CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCNCC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 OETPHHYMNUPPFD-UHFFFAOYSA-N 0.000 description 2
- JCHYVBUYIWCCGT-UHFFFAOYSA-N 6-[3-(4-fluorophenyl)-5-oxo-1,2-dihydropyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2O)C=2C=CC(F)=CC=2)=N1 JCHYVBUYIWCCGT-UHFFFAOYSA-N 0.000 description 2
- IJFPZSANCZDKFH-UHFFFAOYSA-N 6-[3-[[1-(bromomethyl)cyclohexyl]methylamino]-5-(4-fluorophenyl)-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(CBr)CCCCC2)C=2C=CC(F)=CC=2)=N1 IJFPZSANCZDKFH-UHFFFAOYSA-N 0.000 description 2
- IQZNYFHAHXQWME-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[[4-(hydroxymethyl)thian-4-yl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(CO)CCSCC2)C=2C=CC(F)=CC=2)=N1 IQZNYFHAHXQWME-UHFFFAOYSA-N 0.000 description 2
- FKNLIZZEDALVSZ-UHFFFAOYSA-N 6-[5-(ethylamino)-3-(4-fluorophenyl)-1-(2-hydroxyethyl)pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N(CCO)C(NCC)=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 FKNLIZZEDALVSZ-UHFFFAOYSA-N 0.000 description 2
- HRNZQXPXFJIIQV-UHFFFAOYSA-N 6-[6-(4-fluorophenyl)-1-(3-hydroxypropyl)-2,3-dihydroimidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCCO)CCN3N=C2C=2C=CC(F)=CC=2)=N1 HRNZQXPXFJIIQV-UHFFFAOYSA-N 0.000 description 2
- OHOFNHDOSHDLTO-UHFFFAOYSA-N 6-[6-(hydroxymethyl)-2-(3-methylphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC(C=2C(=C3NCC(CO)CN3N=2)C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)=C1 OHOFNHDOSHDLTO-UHFFFAOYSA-N 0.000 description 2
- QVDATXLABOZANN-UHFFFAOYSA-N 6-[6-[(tert-butylamino)methyl]-2-(2,5-difluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC(C)(C)C)CNC3=2)C=2C(=CC=C(F)C=2)F)=N1 QVDATXLABOZANN-UHFFFAOYSA-N 0.000 description 2
- MOWYIYQHBPOTFA-UHFFFAOYSA-N 6-[6-[(tert-butylamino)methyl]-2-(3-methylphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC(C=2C(=C3NCC(CNC(C)(C)C)CN3N=2)C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)=C1 MOWYIYQHBPOTFA-UHFFFAOYSA-N 0.000 description 2
- KLSHSMNMJDGFSW-UHFFFAOYSA-N 6-[6-[(tert-butylamino)methyl]-2-(4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC(C)(C)C)CNC3=2)C=2C=CC(F)=CC=2)=N1 KLSHSMNMJDGFSW-UHFFFAOYSA-N 0.000 description 2
- JMAJKSHPRHKRQM-UHFFFAOYSA-N 6-[[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]methyl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(CC2(OCCO2)C=2C=CC(F)=CC=2)=N1 JMAJKSHPRHKRQM-UHFFFAOYSA-N 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 2
- 208000009386 Experimental Arthritis Diseases 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- UFTDKYWOWFSRDR-UHFFFAOYSA-N [4-(aminomethyl)thian-4-yl]methanol Chemical compound NCC1(CO)CCSCC1 UFTDKYWOWFSRDR-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 2
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- GBPKFZGGBBYYPS-UHFFFAOYSA-N ethyl 2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carboxylate Chemical compound N=1N2CC(C(=O)OCC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 GBPKFZGGBBYYPS-UHFFFAOYSA-N 0.000 description 2
- AJVRNEUOIKQXPI-UHFFFAOYSA-N ethyl 3-[6-(4-fluorophenyl)-7-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-2,3-dihydroimidazo[1,2-b]pyrazol-1-yl]propanoate Chemical compound C=12N(CCC(=O)OCC)CCN2N=C(C=2C=CC(F)=CC=2)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C AJVRNEUOIKQXPI-UHFFFAOYSA-N 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 description 2
- YFJAIURZMRJPDB-UHFFFAOYSA-N n,n-dimethylpiperidin-4-amine Chemical compound CN(C)C1CCNCC1 YFJAIURZMRJPDB-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- FHWQZTLOAMBRSS-UHFFFAOYSA-N tert-butyl 3-[[5-(4-fluorophenyl)-4-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-1H-pyrazol-3-yl]-(3-hydroxypropyl)amino]propanoate Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C(NN=C2C=2C=CC(F)=CC=2)N(CCCO)CCC(=O)OC(C)(C)C)=N1 FHWQZTLOAMBRSS-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 description 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- ZVHHFWKWIVLISO-UHFFFAOYSA-N 1-(azetidin-3-yl)-n,n-dimethylmethanamine;dihydrochloride Chemical compound Cl.Cl.CN(C)CC1CNC1 ZVHHFWKWIVLISO-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- XWRGKNKTGWIUSW-UHFFFAOYSA-N 1-[[2-(2,4-difluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-6-yl]methyl]-3-ethylurea Chemical compound N=1N2CC(CNC(=O)NCC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1F XWRGKNKTGWIUSW-UHFFFAOYSA-N 0.000 description 1
- SEZJHXMCHHSQJP-UHFFFAOYSA-N 1-amino-3-[[4-(hydroxymethyl)thian-4-yl]methyl]thiourea Chemical compound NNC(=S)NCC1(CO)CCSCC1 SEZJHXMCHHSQJP-UHFFFAOYSA-N 0.000 description 1
- SYNFBOHNTFZWDT-UHFFFAOYSA-N 1-amino-3-ethyl-1-(3-hydroxypropyl)thiourea Chemical compound CCNC(=S)N(N)CCCO SYNFBOHNTFZWDT-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- NMUMOSASVMZMAI-UHFFFAOYSA-N 2-(2-methylphenyl)-6-[2-(3-methylphenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,1'-cyclopropane]-3-yl]pyridazin-3-one Chemical compound CC1=CC=CC(C=2C(=C3NCC4(CC4)CN3N=2)C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)=C1 NMUMOSASVMZMAI-UHFFFAOYSA-N 0.000 description 1
- SPBQFEUZCIOBHN-UHFFFAOYSA-N 2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carboxamide Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C(N)=O)C=2C=CC(F)=CC=2)=N1 SPBQFEUZCIOBHN-UHFFFAOYSA-N 0.000 description 1
- OZXNUMAJBZHAKF-UHFFFAOYSA-N 2-(4-fluorophenyl)-N-(2-hydroxyethyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carboxamide Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C(=O)NCCO)C=2C=CC(F)=CC=2)=N1 OZXNUMAJBZHAKF-UHFFFAOYSA-N 0.000 description 1
- YSUHPFLFSFJJCO-UHFFFAOYSA-N 2-(6-chloropyridazin-3-yl)-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC(F)=CC=C1C(=O)CC1=CC=C(Cl)N=N1 YSUHPFLFSFJJCO-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- GBHCABUWWQUMAJ-UHFFFAOYSA-N 2-hydrazinoethanol Chemical compound NNCCO GBHCABUWWQUMAJ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- VNJOEUSYAMPBAK-UHFFFAOYSA-N 2-methylbenzenesulfonic acid;hydrate Chemical compound O.CC1=CC=CC=C1S(O)(=O)=O VNJOEUSYAMPBAK-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- AWGBKZRMLNVLAF-UHFFFAOYSA-N 3,5-dibromo-n,2-dihydroxybenzamide Chemical compound ONC(=O)C1=CC(Br)=CC(Br)=C1O AWGBKZRMLNVLAF-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- KAEJEMIMQAEMFX-UHFFFAOYSA-N 3-[1-bromo-2-(2,4-difluorophenyl)-2-oxoethyl]-1h-pyridazin-6-one Chemical compound FC1=CC(F)=CC=C1C(=O)C(Br)C1=NNC(=O)C=C1 KAEJEMIMQAEMFX-UHFFFAOYSA-N 0.000 description 1
- OCGVCHCDGKQCID-UHFFFAOYSA-N 3-[2-(2,4-difluorophenyl)-2-oxoethyl]-1h-pyridazin-6-one Chemical compound FC1=CC(F)=CC=C1C(=O)CC1=NNC(=O)C=C1 OCGVCHCDGKQCID-UHFFFAOYSA-N 0.000 description 1
- BTTFCSKLYAKZLV-UHFFFAOYSA-N 3-[2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-6,7-dihydro-5h-pyrazolo[1,5-a]pyrimidin-4-yl]propanoic acid Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCC(O)=O)CCCN3N=C2C=2C=CC(F)=CC=2)=N1 BTTFCSKLYAKZLV-UHFFFAOYSA-N 0.000 description 1
- HREHCYXOFYPKOP-UHFFFAOYSA-N 3-amino-1-methyl-1-phenylthiourea Chemical compound NNC(=S)N(C)C1=CC=CC=C1 HREHCYXOFYPKOP-UHFFFAOYSA-N 0.000 description 1
- PRORLQAJNJMGAR-UHFFFAOYSA-N 3-chloro-6-methylpyridazine Chemical compound CC1=CC=C(Cl)N=N1 PRORLQAJNJMGAR-UHFFFAOYSA-N 0.000 description 1
- ZJQWXXSZXSTKHW-UHFFFAOYSA-N 3-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1.OOC(=O)C1=CC=CC(Cl)=C1 ZJQWXXSZXSTKHW-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- JLAKCHGEEBPDQI-UHFFFAOYSA-N 4-(4-fluorobenzyl)piperidine Chemical compound C1=CC(F)=CC=C1CC1CCNCC1 JLAKCHGEEBPDQI-UHFFFAOYSA-N 0.000 description 1
- GOUOHYSLMSYSPW-UHFFFAOYSA-N 4-(hydroxymethyl)thiane-4-carbonitrile Chemical compound OCC1(C#N)CCSCC1 GOUOHYSLMSYSPW-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- ZXIOBRHNYMMLDV-UHFFFAOYSA-N 6-(5-acetyl-2-phenyl-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazin-3-yl)-2-(2-methylphenyl)pyridazin-3-one Chemical compound C=12CN(C(=O)C)CCN2N=C(C=2C=CC=CC=2)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C ZXIOBRHNYMMLDV-UHFFFAOYSA-N 0.000 description 1
- GEQNDQPPLLXGIJ-QGZVFWFLSA-N 6-[(2R)-6-(4-fluorophenyl)-2-(hydroxymethyl)-2,3-dihydro-1H-imidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound FC1=CC=C(C=C1)C=1C(=C2N(N1)C[C@@H](N2)CO)C=2C=CC(N(N2)C2=C(C=CC=C2)C)=O GEQNDQPPLLXGIJ-QGZVFWFLSA-N 0.000 description 1
- BEUIWWHWGNUVSJ-XMMPIXPASA-N 6-[(2R)-6-(4-fluorophenyl)-2-(phenylmethoxymethyl)-2,3-dihydro-1H-imidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@H](COCC=4C=CC=CC=4)NC3=2)C=2C=CC(F)=CC=2)=N1 BEUIWWHWGNUVSJ-XMMPIXPASA-N 0.000 description 1
- KLBDYKQTHLWFNO-OAHLLOKOSA-N 6-[(2R)-6-(4-fluorophenyl)-2-methyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C([C@H](NC1=2)C)N1N=C(C=1C=CC(F)=CC=1)C=2C(=N1)C=CC(=O)N1C1=CC=CC=C1C KLBDYKQTHLWFNO-OAHLLOKOSA-N 0.000 description 1
- GEQNDQPPLLXGIJ-KRWDZBQOSA-N 6-[(2S)-6-(4-fluorophenyl)-2-(hydroxymethyl)-2,3-dihydro-1H-imidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@@H](CO)NC3=2)C=2C=CC(F)=CC=2)=N1 GEQNDQPPLLXGIJ-KRWDZBQOSA-N 0.000 description 1
- BEUIWWHWGNUVSJ-DEOSSOPVSA-N 6-[(2S)-6-(4-fluorophenyl)-2-(phenylmethoxymethyl)-2,3-dihydro-1H-imidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@@H](COCC=4C=CC=CC=4)NC3=2)C=2C=CC(F)=CC=2)=N1 BEUIWWHWGNUVSJ-DEOSSOPVSA-N 0.000 description 1
- IQDRAWBHXSOJFB-CQSZACIVSA-N 6-[(3R)-6-(2,4-difluorophenyl)-3-methyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C([C@H](N1N=2)C)NC1=C(C1=NN(C(=O)C=C1)C=1C(=CC=CC=1)C)C=2C1=CC=C(F)C=C1F IQDRAWBHXSOJFB-CQSZACIVSA-N 0.000 description 1
- IQDRAWBHXSOJFB-AWEZNQCLSA-N 6-[(3S)-6-(2,4-difluorophenyl)-3-methyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C([C@@H](N1N=2)C)NC1=C(C1=NN(C(=O)C=C1)C=1C(=CC=CC=1)C)C=2C1=CC=C(F)C=C1F IQDRAWBHXSOJFB-AWEZNQCLSA-N 0.000 description 1
- XDHQIVYBPKRWMO-WJOKGBTCSA-N 6-[(5R)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-(4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC[C@H](CO[Si](C=4C=CC=CC=4)(C=4C=CC=CC=4)C(C)(C)C)NC3=2)C=2C=CC(F)=CC=2)=N1 XDHQIVYBPKRWMO-WJOKGBTCSA-N 0.000 description 1
- YTVBZTSZGHTOSO-OAHLLOKOSA-N 6-[(6R)-2-(2,4-difluorophenyl)-6-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@H](O)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 YTVBZTSZGHTOSO-OAHLLOKOSA-N 0.000 description 1
- CVSSLCZZPVLZEE-JOCHJYFZSA-N 6-[(6R)-2-(2,4-difluorophenyl)-6-phenylmethoxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@@H](CNC3=2)OCC=2C=CC=CC=2)C=2C(=CC(F)=CC=2)F)=N1 CVSSLCZZPVLZEE-JOCHJYFZSA-N 0.000 description 1
- YTVBZTSZGHTOSO-HNNXBMFYSA-N 6-[(6S)-2-(2,4-difluorophenyl)-6-hydroxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@@H](O)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 YTVBZTSZGHTOSO-HNNXBMFYSA-N 0.000 description 1
- CVSSLCZZPVLZEE-QFIPXVFZSA-N 6-[(6S)-2-(2,4-difluorophenyl)-6-phenylmethoxy-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3C[C@H](CNC3=2)OCC=2C=CC=CC=2)C=2C(=CC(F)=CC=2)F)=N1 CVSSLCZZPVLZEE-QFIPXVFZSA-N 0.000 description 1
- WFBOVZJGUWQGMR-YBEGLDIGSA-N 6-[(6Z)-2-(2,4-difluorophenyl)-6-(2-hydroxyethylidene)-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(/CNC3=2)=C\CO)C=2C(=CC(F)=CC=2)F)=N1 WFBOVZJGUWQGMR-YBEGLDIGSA-N 0.000 description 1
- YVEVKRJUDXKFFN-UHFFFAOYSA-N 6-[1'-ethyl-2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-piperidine]-3-yl]-2-(2-methylphenyl)pyridazin-3-one hydrochloride Chemical compound Cl.CCN1CCC2(CC1)CNc1c(c(nn1C2)-c1ccc(F)cc1)-c1ccc(=O)n(n1)-c1ccccc1C YVEVKRJUDXKFFN-UHFFFAOYSA-N 0.000 description 1
- PTJWOGMRIAMKAC-UHFFFAOYSA-N 6-[1-bromo-2-(4-fluorophenyl)-2-oxoethyl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C(Br)C(=O)C=2C=CC(F)=CC=2)=N1 PTJWOGMRIAMKAC-UHFFFAOYSA-N 0.000 description 1
- SYTPWERMOJEGDX-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-1'-propan-2-ylspiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,3'-azetidine]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C1N(C(C)C)CC21CN1N=C(C=3C(=CC(F)=CC=3)F)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C1NC2 SYTPWERMOJEGDX-UHFFFAOYSA-N 0.000 description 1
- LVEPNPSPHAFEJP-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-2-oxoethyl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(CC(=O)C=2C(=CC(F)=CC=2)F)=N1 LVEPNPSPHAFEJP-UHFFFAOYSA-N 0.000 description 1
- IYPZYGOMKHRKBC-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)-6-[(4-methylpiperazin-1-yl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C1CN(C)CCN1CC1CN2N=C(C=3C(=CC(F)=CC=3)F)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C2NC1 IYPZYGOMKHRKBC-UHFFFAOYSA-N 0.000 description 1
- AMWJVPKJVCLIHB-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,1'-cyclobutane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound FC1=C(C=CC(=C1)F)C1=NN2C(NCC3(CCC3)C2)=C1C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O AMWJVPKJVCLIHB-UHFFFAOYSA-N 0.000 description 1
- COLDRXFPUQNFPN-UHFFFAOYSA-N 6-[2-(2,4-difluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,1'-cyclopropane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CC4)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 COLDRXFPUQNFPN-UHFFFAOYSA-N 0.000 description 1
- ZBGYZCUJOKMKMN-UHFFFAOYSA-N 6-[2-(2,5-difluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CO)CNC3=2)C=2C(=CC=C(F)C=2)F)=N1 ZBGYZCUJOKMKMN-UHFFFAOYSA-N 0.000 description 1
- FTCKGEIDCRJVCG-UHFFFAOYSA-N 6-[2-(2,5-difluorophenyl)-6-[(dimethylamino)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC(F)=CC=C1F FTCKGEIDCRJVCG-UHFFFAOYSA-N 0.000 description 1
- RQOOVTCYGKQYOI-UHFFFAOYSA-N 6-[2-(2-chloro-4-fluorophenyl)-6,6-bis(hydroxymethyl)-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CO)(CO)CNC3=2)C=2C(=CC(F)=CC=2)Cl)=N1 RQOOVTCYGKQYOI-UHFFFAOYSA-N 0.000 description 1
- INIHMYQXDIQSQR-UHFFFAOYSA-N 6-[2-(2-chloro-4-fluorophenyl)-6-(methylaminomethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CNC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1Cl INIHMYQXDIQSQR-UHFFFAOYSA-N 0.000 description 1
- AFFATFHXRWSSHY-UHFFFAOYSA-N 6-[2-(2-chloro-4-fluorophenyl)-6-[(dimethylamino)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1Cl AFFATFHXRWSSHY-UHFFFAOYSA-N 0.000 description 1
- AFVIRIYUJLGGMZ-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-1',1'-dioxospiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-thiane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCS(=O)(=O)CC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 AFVIRIYUJLGGMZ-UHFFFAOYSA-N 0.000 description 1
- IGUPPNZERNKUTI-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-1'-(2-hydroxyethyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-piperidine]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCN(CCO)CC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 IGUPPNZERNKUTI-UHFFFAOYSA-N 0.000 description 1
- UAUMHMOZCGYNCZ-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-4-(3-hydroxypropyl)-6,7-dihydro-5h-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCCO)CCCN3N=C2C=2C=CC(F)=CC=2)=N1 UAUMHMOZCGYNCZ-UHFFFAOYSA-N 0.000 description 1
- VOPMTLIZIJUTGT-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CCCCOC3=2)C=2C=CC(F)=CC=2)=N1 VOPMTLIZIJUTGT-UHFFFAOYSA-N 0.000 description 1
- BCTHKQIWGNWHPO-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CCCOC3=2)C=2C=CC(F)=CC=2)=N1 BCTHKQIWGNWHPO-UHFFFAOYSA-N 0.000 description 1
- SEYFUGFWXACBNN-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-(hydroxymethyl)pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N=CC(CO)=CN3N=C2C=2C=CC(F)=CC=2)=N1 SEYFUGFWXACBNN-UHFFFAOYSA-N 0.000 description 1
- DAPSPFOUKWKYJO-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-(morpholin-4-ylmethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one hydrochloride Chemical compound Cl.CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CN4CCOCC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 DAPSPFOUKWKYJO-UHFFFAOYSA-N 0.000 description 1
- WKXKZDMPLVIEEF-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-(propan-2-ylamino)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(NC(C)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 WKXKZDMPLVIEEF-UHFFFAOYSA-N 0.000 description 1
- IRYCISXFCUVJBC-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-[(2-methoxyethylamino)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CNCCOC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 IRYCISXFCUVJBC-UHFFFAOYSA-N 0.000 description 1
- AHJVLACJTDNVOB-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-[(2-methylpropan-2-yl)oxymethyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(COC(C)(C)C)CNC3=2)C=2C=CC(F)=CC=2)=N1 AHJVLACJTDNVOB-UHFFFAOYSA-N 0.000 description 1
- ZDCZCZCACDUDNJ-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-[(3-hydroxyazetidin-1-yl)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CN4CC(O)C4)CNC3=2)C=2C=CC(F)=CC=2)=N1 ZDCZCZCACDUDNJ-UHFFFAOYSA-N 0.000 description 1
- CMWCLBYGHBAWOI-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-[[2-hydroxyethyl(methyl)amino]methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one hydrochloride Chemical compound Cl.N=1N2CC(CN(CCO)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 CMWCLBYGHBAWOI-UHFFFAOYSA-N 0.000 description 1
- ZAUZAHHDIIWNFZ-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 ZAUZAHHDIIWNFZ-UHFFFAOYSA-N 0.000 description 1
- FDNDRBYWQCGJOB-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6-morpholin-4-yl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)N2CCOCC2)C=2C=CC(F)=CC=2)=N1 FDNDRBYWQCGJOB-UHFFFAOYSA-N 0.000 description 1
- WLJFHEXBKDDRLC-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,1'-cyclobutane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 WLJFHEXBKDDRLC-UHFFFAOYSA-N 0.000 description 1
- DBSUNHKUFXFTMW-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,1'-cyclohexane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCCCC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 DBSUNHKUFXFTMW-UHFFFAOYSA-N 0.000 description 1
- WIIGHVVNLSOPGM-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,1'-cyclopentane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCCC4)CNC3=2)C=2C=CC(F)=CC=2)=N1 WIIGHVVNLSOPGM-UHFFFAOYSA-N 0.000 description 1
- LXSQJIJSARXPNE-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,1'-cyclopropane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound Cc1ccccc1-n1nc(ccc1=O)-c1c2NCC3(CC3)Cn2nc1-c1ccc(F)cc1 LXSQJIJSARXPNE-UHFFFAOYSA-N 0.000 description 1
- BSJMBSPVSQKHKV-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-thiane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound FC1=CC=C(C=C1)C1=NN2C(NCC3(C2)CCSCC3)=C1C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O BSJMBSPVSQKHKV-UHFFFAOYSA-N 0.000 description 1
- DGIUPEWAYXOFMN-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[6,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-5,4'-oxane]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CCC4(CCOCC4)NC3=2)C=2C=CC(F)=CC=2)=N1 DGIUPEWAYXOFMN-UHFFFAOYSA-N 0.000 description 1
- FVTBQHIZKDIPGM-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)spiro[6,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-5,4'-piperidine]-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CCC4(CCNCC4)NC3=2)C=2C=CC(F)=CC=2)=N1 FVTBQHIZKDIPGM-UHFFFAOYSA-N 0.000 description 1
- OFOZYHWCAIWHTG-UHFFFAOYSA-N 6-[3-[(3-bromo-2,2-difluoropropyl)amino]-5-(4-fluorophenyl)-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC(F)(F)CBr)C=2C=CC(F)=CC=2)=N1 OFOZYHWCAIWHTG-UHFFFAOYSA-N 0.000 description 1
- RZJYGPBMFYKGMH-HKBQPEDESA-N 6-[3-[[(2S)-1-[tert-butyl(diphenyl)silyl]oxy-4-hydroxybutan-2-yl]amino]-5-(4-fluorophenyl)-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2N[C@@H](CCO)CO[Si](C=2C=CC=CC=2)(C=2C=CC=CC=2)C(C)(C)C)C=2C=CC(F)=CC=2)=N1 RZJYGPBMFYKGMH-HKBQPEDESA-N 0.000 description 1
- POJFENZIRCOYAW-UHFFFAOYSA-N 6-[3-[[1,1-dioxo-4-(phenylmethoxymethyl)thian-4-yl]methylamino]-5-(4-fluorophenyl)-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(COCC=3C=CC=CC=3)CCS(=O)(=O)CC2)C=2C=CC(F)=CC=2)=N1 POJFENZIRCOYAW-UHFFFAOYSA-N 0.000 description 1
- ROZHQKDONNGRKA-UHFFFAOYSA-N 6-[3-[[1-(hydroxymethyl)cyclopropyl]methylamino]-5-(3-methylphenyl)-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC(C=2C(=C(NCC3(CO)CC3)NN=2)C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)=C1 ROZHQKDONNGRKA-UHFFFAOYSA-N 0.000 description 1
- QZKLUZBNDKRRSA-UHFFFAOYSA-N 6-[4-ethyl-2-(4-fluorophenyl)-6,7-dihydro-5h-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C=12N(CC)CCCN2N=C(C=2C=CC(F)=CC=2)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C QZKLUZBNDKRRSA-UHFFFAOYSA-N 0.000 description 1
- GRHRVBBRIOFISH-UHFFFAOYSA-N 6-[5-(2,4-difluorophenyl)-3-(4-hydroxybutan-2-ylamino)-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound OCCC(C)NC=1NN=C(C=2C(=CC(F)=CC=2)F)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C GRHRVBBRIOFISH-UHFFFAOYSA-N 0.000 description 1
- BIUHFDCJJFLUFK-KRWDZBQOSA-N 6-[5-(2,4-difluorophenyl)-3-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C(NN=C2C=2C(=CC(F)=CC=2)F)N2[C@@H](CCC2)CO)=N1 BIUHFDCJJFLUFK-KRWDZBQOSA-N 0.000 description 1
- YGNBPSOVRGCFIR-CQSZACIVSA-N 6-[5-(2,4-difluorophenyl)-3-[[(2R)-2-hydroxypropyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C[C@@H](O)CNC=1NN=C(C=2C(=CC(F)=CC=2)F)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C YGNBPSOVRGCFIR-CQSZACIVSA-N 0.000 description 1
- XSVSPTUJFMTGMK-JOCHJYFZSA-N 6-[5-(2,4-difluorophenyl)-3-[[(2R)-3-hydroxy-2-phenylmethoxypropyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NC[C@H](CO)OCC=2C=CC=CC=2)C=2C(=CC(F)=CC=2)F)=N1 XSVSPTUJFMTGMK-JOCHJYFZSA-N 0.000 description 1
- BTEBWCQHBOQUBF-IBGZPJMESA-N 6-[5-(2,4-difluorophenyl)-3-[[(2S)-2-(2,2-dimethylpropoxy)-3-hydroxypropyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NC[C@@H](CO)OCC(C)(C)C)C=2C(=CC(F)=CC=2)F)=N1 BTEBWCQHBOQUBF-IBGZPJMESA-N 0.000 description 1
- YGNBPSOVRGCFIR-AWEZNQCLSA-N 6-[5-(2,4-difluorophenyl)-3-[[(2S)-2-hydroxypropyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C[C@H](O)CNC=1NN=C(C=2C(=CC(F)=CC=2)F)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C YGNBPSOVRGCFIR-AWEZNQCLSA-N 0.000 description 1
- XSVSPTUJFMTGMK-QFIPXVFZSA-N 6-[5-(2,4-difluorophenyl)-3-[[(2S)-3-hydroxy-2-phenylmethoxypropyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NC[C@@H](CO)OCC=2C=CC=CC=2)C=2C(=CC(F)=CC=2)F)=N1 XSVSPTUJFMTGMK-QFIPXVFZSA-N 0.000 description 1
- ZBDLPIHIGBJQSW-UHFFFAOYSA-N 6-[5-(2,4-difluorophenyl)-3-[[1-(hydroxymethyl)cyclobutyl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(CO)CCC2)C=2C(=CC(F)=CC=2)F)=N1 ZBDLPIHIGBJQSW-UHFFFAOYSA-N 0.000 description 1
- XWLZFQYBNXMLOI-UHFFFAOYSA-N 6-[5-(2,4-difluorophenyl)-3-[[1-(hydroxymethyl)cyclopropyl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(CO)CC2)C=2C(=CC(F)=CC=2)F)=N1 XWLZFQYBNXMLOI-UHFFFAOYSA-N 0.000 description 1
- OAEAIALNNYJUCW-UHFFFAOYSA-N 6-[5-(2,4-difluorophenyl)-3-[[3-(hydroxymethyl)-1-propan-2-ylazetidin-3-yl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound FC1=C(C=CC(=C1)F)C1=NNC(=C1C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O)NCC1(CN(C1)C(C)C)CO OAEAIALNNYJUCW-UHFFFAOYSA-N 0.000 description 1
- XQEMUHJMVBQFMZ-UHFFFAOYSA-N 6-[5-(2,4-difluorophenyl)-3-[[3-(hydroxymethyl)azetidin-3-yl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(CO)CNC2)C=2C(=CC(F)=CC=2)F)=N1 XQEMUHJMVBQFMZ-UHFFFAOYSA-N 0.000 description 1
- RFDUKUVNOMTUML-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-hydroxyethylamino)-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCCO)C=2C=CC(F)=CC=2)=N1 RFDUKUVNOMTUML-UHFFFAOYSA-N 0.000 description 1
- DUUMSTRXDRZHMO-XMMPIXPASA-N 6-[5-(4-fluorophenyl)-3-[[(2R)-1-hydroxy-3-phenylmethoxypropan-2-yl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2N[C@H](CO)COCC=2C=CC=CC=2)C=2C=CC(F)=CC=2)=N1 DUUMSTRXDRZHMO-XMMPIXPASA-N 0.000 description 1
- BGAWFBPWJBJWQQ-XMMPIXPASA-N 6-[5-(4-fluorophenyl)-3-[[(2R)-3-hydroxy-2-phenylmethoxypropyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C(C1=CC=CC=C1)O[C@H](CNC1=C(C(=NN1)C1=CC=C(C=C1)F)C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O)CO BGAWFBPWJBJWQQ-XMMPIXPASA-N 0.000 description 1
- DUUMSTRXDRZHMO-DEOSSOPVSA-N 6-[5-(4-fluorophenyl)-3-[[(2S)-1-hydroxy-3-phenylmethoxypropan-2-yl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C(C1=CC=CC=C1)OC[C@H](CO)NC1=C(C(=NN1)C1=CC=C(C=C1)F)C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O DUUMSTRXDRZHMO-DEOSSOPVSA-N 0.000 description 1
- BGAWFBPWJBJWQQ-DEOSSOPVSA-N 6-[5-(4-fluorophenyl)-3-[[(2S)-3-hydroxy-2-phenylmethoxypropyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound C(C1=CC=CC=C1)O[C@@H](CNC1=C(C(=NN1)C1=CC=C(C=C1)F)C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O)CO BGAWFBPWJBJWQQ-DEOSSOPVSA-N 0.000 description 1
- MQJDMIHVURRJJI-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[[1-(hydroxymethyl)cyclobutyl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound FC1=CC=C(C=C1)C1=NNC(=C1C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O)NCC1(CCC1)CO MQJDMIHVURRJJI-UHFFFAOYSA-N 0.000 description 1
- FZJMYEUCDVULBZ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[[1-(hydroxymethyl)cyclopropyl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(CO)CC2)C=2C=CC(F)=CC=2)=N1 FZJMYEUCDVULBZ-UHFFFAOYSA-N 0.000 description 1
- JJVHPWQXIAMHGP-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[[2-(hydroxymethyl)-3-[(2-methylpropan-2-yl)oxy]propyl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC(CO)COC(C)(C)C)C=2C=CC(F)=CC=2)=N1 JJVHPWQXIAMHGP-UHFFFAOYSA-N 0.000 description 1
- ULNZFSAEAINDOS-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[[4-(2-hydroxyethyl)oxan-4-yl]amino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound FC1=CC=C(C=C1)C1=NNC(=C1C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O)NC1(CCOCC1)CCO ULNZFSAEAINDOS-UHFFFAOYSA-N 0.000 description 1
- XLBUWWWAKXOJJA-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[[4-(hydroxymethyl)-1,1-dioxothian-4-yl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound FC1=CC=C(C=C1)C1=NNC(=C1C=1C=CC(N(N1)C1=C(C=CC=C1)C)=O)NCC1(CCS(CC1)(=O)=O)CO XLBUWWWAKXOJJA-UHFFFAOYSA-N 0.000 description 1
- CPBZHGVVVSXEQL-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[[4-(hydroxymethyl)oxan-4-yl]methylamino]-1H-pyrazol-4-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NNC=2NCC2(CO)CCOCC2)C=2C=CC(F)=CC=2)=N1 CPBZHGVVVSXEQL-UHFFFAOYSA-N 0.000 description 1
- YXGLCTJQBWZIHC-UHFFFAOYSA-N 6-[6,6-bis(hydroxymethyl)-2-(3-methylphenyl)-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC(C=2C(=C3NCC(CO)(CO)CN3N=2)C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)=C1 YXGLCTJQBWZIHC-UHFFFAOYSA-N 0.000 description 1
- VLISFZVUIJLKDN-UHFFFAOYSA-N 6-[6,6-difluoro-2-(4-fluorophenyl)-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(F)(F)CNC3=2)C=2C=CC(F)=CC=2)=N1 VLISFZVUIJLKDN-UHFFFAOYSA-N 0.000 description 1
- RDHTUIPLNAAOIM-UHFFFAOYSA-N 6-[6-(2,4-difluorophenyl)-2,2-dimethyl-1,3-dihydroimidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound Cc1ccccc1-n1nc(ccc1=O)-c1c2NC(C)(C)Cn2nc1-c1ccc(F)cc1F RDHTUIPLNAAOIM-UHFFFAOYSA-N 0.000 description 1
- LESSYMIPBKZAGW-UHFFFAOYSA-N 6-[6-(4-fluorophenyl)-1-(3-morpholin-4-yl-3-oxopropyl)-2,3-dihydroimidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCC(=O)N4CCOCC4)CCN3N=C2C=2C=CC(F)=CC=2)=N1 LESSYMIPBKZAGW-UHFFFAOYSA-N 0.000 description 1
- UYHOWMMOZFOSCD-UHFFFAOYSA-N 6-[6-(4-fluorophenyl)-1-(3-morpholin-4-ylpropyl)-2,3-dihydroimidazo[1,2-b]pyrazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCCN4CCOCC4)CCN3N=C2C=2C=CC(F)=CC=2)=N1 UYHOWMMOZFOSCD-UHFFFAOYSA-N 0.000 description 1
- NHZUCSCRAQJJPF-UHFFFAOYSA-N 6-[6-(4-fluorophenyl)-2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CCOC3=2)C=2C=CC(F)=CC=2)=N1 NHZUCSCRAQJJPF-UHFFFAOYSA-N 0.000 description 1
- VIFHJSXUQNFBQF-UHFFFAOYSA-N 6-[6-(aminomethyl)-2-(2,4-difluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CN)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 VIFHJSXUQNFBQF-UHFFFAOYSA-N 0.000 description 1
- UIBBLNNMSQPPAQ-UHFFFAOYSA-N 6-[6-(diethylaminomethyl)-2-(2,5-difluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(CC)CC)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC(F)=CC=C1F UIBBLNNMSQPPAQ-UHFFFAOYSA-N 0.000 description 1
- ZUOOJMPPCLOLON-UHFFFAOYSA-N 6-[6-[(dibenzylamino)methyl]-2-(2,4-difluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CN(CC=4C=CC=CC=4)CC=4C=CC=CC=4)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 ZUOOJMPPCLOLON-UHFFFAOYSA-N 0.000 description 1
- AVVPXHHWRGMYIR-UHFFFAOYSA-N 6-[6-[(dimethylamino)methyl]-2-(3,5-dimethylphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC(C)=CC(C)=C1 AVVPXHHWRGMYIR-UHFFFAOYSA-N 0.000 description 1
- UDJMXJOLNPETAE-UHFFFAOYSA-N 6-[6-[(dimethylamino)methyl]-2-(3-methoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound COC1=CC=CC(C=2C(=C3NCC(CN(C)C)CN3N=2)C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)=C1 UDJMXJOLNPETAE-UHFFFAOYSA-N 0.000 description 1
- SZNAGKHHHFYNLR-UHFFFAOYSA-N 6-[6-[(dimethylamino)methyl]-2-(3-methylphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=CC(C)=C1 SZNAGKHHHFYNLR-UHFFFAOYSA-N 0.000 description 1
- FPJXLYQKGIRHQZ-UHFFFAOYSA-N 6-[6-[(dimethylamino)methyl]-2-(4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound N=1N2CC(CN(C)C)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=C(F)C=C1 FPJXLYQKGIRHQZ-UHFFFAOYSA-N 0.000 description 1
- JPGXILJVSGRYFP-UHFFFAOYSA-N 6-[6-[[4-(dimethylamino)piperidin-1-yl]methyl]-2-(4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one dihydrochloride Chemical compound Cl.Cl.C1CC(N(C)C)CCN1CC1CN2N=C(C=3C=CC(F)=CC=3)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C2NC1 JPGXILJVSGRYFP-UHFFFAOYSA-N 0.000 description 1
- TXWUAQDBVXXCHC-UHFFFAOYSA-N 6-[6-[[benzyl(tert-butyl)amino]methyl]-2-(2,4-difluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CN(CC=4C=CC=CC=4)C(C)(C)C)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 TXWUAQDBVXXCHC-UHFFFAOYSA-N 0.000 description 1
- KMWOWJYIDNTRSL-UHFFFAOYSA-N 6-[[2-(2,4-difluorophenyl)-1,3-dioxolan-2-yl]methyl]-2-(2-methylphenyl)pyridazin-3-one Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(CC2(OCCO2)C=2C(=CC(F)=CC=2)F)=N1 KMWOWJYIDNTRSL-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- OBNVMDZVRXRTNG-UHFFFAOYSA-N N-[[2-(2,4-difluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-6-yl]methyl]cyclopropanecarboxamide Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC(=O)C4CC4)CNC3=2)C=2C(=CC(F)=CC=2)F)=N1 OBNVMDZVRXRTNG-UHFFFAOYSA-N 0.000 description 1
- QVUXQVOMHMBEEZ-UHFFFAOYSA-N N-cyclopropyl-2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-6-carboxamide Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC(CNC3=2)C(=O)NC2CC2)C=2C=CC(F)=CC=2)=N1 QVUXQVOMHMBEEZ-UHFFFAOYSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- JOOQUDOQQDCHNS-UHFFFAOYSA-N N-tert-butyl-2-[3-[2-(2,4-difluorophenyl)-6-[(dimethylamino)methyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-6-oxopyridazin-1-yl]benzenesulfonamide Chemical compound C(C)(C)(C)NS(=O)(=O)C1=C(C=CC=C1)N1N=C(C=CC1=O)C=1C(=NN2C1NCC(C2)CN(C)C)C2=C(C=C(C=C2)F)F JOOQUDOQQDCHNS-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- TUEIURIZJQRMQE-UHFFFAOYSA-N [2-(tert-butylsulfamoyl)phenyl]boronic acid Chemical compound CC(C)(C)NS(=O)(=O)C1=CC=CC=C1B(O)O TUEIURIZJQRMQE-UHFFFAOYSA-N 0.000 description 1
- ZDKCUXNEOIGZGP-UHFFFAOYSA-N [6-(acetyloxymethyl)-2-(3-methylphenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidin-6-yl]methyl acetate Chemical compound N=1N2CC(COC(=O)C)(COC(C)=O)CNC2=C(C2=NN(C(=O)C=C2)C=2C(=CC=CC=2)C)C=1C1=CC=CC(C)=C1 ZDKCUXNEOIGZGP-UHFFFAOYSA-N 0.000 description 1
- RAFKCLFWELPONH-UHFFFAOYSA-N acetonitrile;dichloromethane Chemical compound CC#N.ClCCl RAFKCLFWELPONH-UHFFFAOYSA-N 0.000 description 1
- XLUXHEZIGIDTCC-UHFFFAOYSA-N acetonitrile;ethyl acetate Chemical compound CC#N.CCOC(C)=O XLUXHEZIGIDTCC-UHFFFAOYSA-N 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000006251 butylcarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- KVJGAHKNJAOOOG-UHFFFAOYSA-N chembl2170289 Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CCNC3=2)C=2C=CC(F)=CC=2)=N1 KVJGAHKNJAOOOG-UHFFFAOYSA-N 0.000 description 1
- NXGJJGDJORGQRV-UHFFFAOYSA-N chembl2170296 Chemical compound C1CN(C)CCN1CC1CN2N=C(C=3C=CC(F)=CC=3)C(C3=NN(C(=O)C=C3)C=3C(=CC=CC=3)C)=C2NC1 NXGJJGDJORGQRV-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004212 difluorophenyl group Chemical group 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 238000011549 displacement method Methods 0.000 description 1
- UZZWBUYVTBPQIV-UHFFFAOYSA-N dme dimethoxyethane Chemical compound COCCOC.COCCOC UZZWBUYVTBPQIV-UHFFFAOYSA-N 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- LHWWETDBWVTKJO-UHFFFAOYSA-N et3n triethylamine Chemical compound CCN(CC)CC.CCN(CC)CC LHWWETDBWVTKJO-UHFFFAOYSA-N 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- DKFPMOKJSUTTLS-UHFFFAOYSA-N ethyl 2-[2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-4,5-dihydropyrazolo[1,5-a]pyrimidin-6-yl]acetate Chemical compound FC1=CC=C(C=C1)C1=NN2C(NCC(=C2)CC(=O)OCC)=C1C1=NN(C(C=C1)=O)C1=C(C=CC=C1)C DKFPMOKJSUTTLS-UHFFFAOYSA-N 0.000 description 1
- SXGKAGQCXMPPTM-UHFFFAOYSA-N ethyl 2-[[[5-(2,4-difluorophenyl)-4-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-1H-pyrazol-3-yl]amino]methyl]-3-hydroxypropanoate Chemical compound CCOC(=O)C(CO)CNC=1NN=C(C=2C(=CC(F)=CC=2)F)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C SXGKAGQCXMPPTM-UHFFFAOYSA-N 0.000 description 1
- HYMQACVXIKXELB-UHFFFAOYSA-N ethyl 2-[[[5-(4-fluorophenyl)-4-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-1H-pyrazol-3-yl]amino]methyl]-3-hydroxypropanoate Chemical compound CCOC(=O)C(CO)CNC=1NN=C(C=2C=CC(F)=CC=2)C=1C(=N1)C=CC(=O)N1C1=CC=CC=C1C HYMQACVXIKXELB-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- MEALHOPAGPQCDD-UHFFFAOYSA-N ethyl 3-[[amino(2-hydroxyethyl)carbamothioyl]amino]propanoate Chemical compound CCOC(=O)CCNC(=S)N(N)CCO MEALHOPAGPQCDD-UHFFFAOYSA-N 0.000 description 1
- UPTRONYNXNYITM-UHFFFAOYSA-N ethyl 3-isothiocyanatopropanoate Chemical compound CCOC(=O)CCN=C=S UPTRONYNXNYITM-UHFFFAOYSA-N 0.000 description 1
- UMPRJGKLMUDRHL-UHFFFAOYSA-N ethyl 4-fluorobenzoate Chemical compound CCOC(=O)C1=CC=C(F)C=C1 UMPRJGKLMUDRHL-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- MSMGXWFHBSCQFB-UHFFFAOYSA-N ethyl cyanoformate Chemical compound CCOC(=O)C#N MSMGXWFHBSCQFB-UHFFFAOYSA-N 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004871 hexylcarbonyl group Chemical group C(CCCCC)C(=O)* 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 238000011694 lewis rat Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000006261 methyl amino sulfonyl group Chemical group [H]N(C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 125000004675 pentylcarbonyl group Chemical group C(CCCC)C(=O)* 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004673 propylcarbonyl group Chemical group 0.000 description 1
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 1
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 description 1
- JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940116176 remicade Drugs 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- WGRULTCAYDOGQK-UHFFFAOYSA-M sodium;sodium;hydroxide Chemical compound [OH-].[Na].[Na+] WGRULTCAYDOGQK-UHFFFAOYSA-M 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- QUZYTDRPYNTOON-UHFFFAOYSA-N tert-butyl 2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]spiro[5,7-dihydro-4H-pyrazolo[1,5-a]pyrimidine-6,4'-piperidine]-1'-carboxylate Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C=2C(=NN3CC4(CCN(CC4)C(=O)OC(C)(C)C)CNC3=2)C=2C=CC(F)=CC=2)=N1 QUZYTDRPYNTOON-UHFFFAOYSA-N 0.000 description 1
- YPFOWQPSUFQSGV-UHFFFAOYSA-N tert-butyl 3-[2-(4-fluorophenyl)-3-[1-(2-methylphenyl)-6-oxopyridazin-3-yl]-6,7-dihydro-5h-pyrazolo[1,5-a]pyrimidin-4-yl]propanoate Chemical compound CC1=CC=CC=C1N1C(=O)C=CC(C2=C3N(CCC(=O)OC(C)(C)C)CCCN3N=C2C=2C=CC(F)=CC=2)=N1 YPFOWQPSUFQSGV-UHFFFAOYSA-N 0.000 description 1
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- PHCBRBWANGJMHS-UHFFFAOYSA-J tetrasodium;disulfate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O PHCBRBWANGJMHS-UHFFFAOYSA-J 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/20—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71282505P | 2005-09-01 | 2005-09-01 | |
| US60/712,825 | 2005-09-01 | ||
| PCT/JP2006/317691 WO2007026950A1 (en) | 2005-09-01 | 2006-08-31 | Pyridazinone derivatives used for the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2620740A1 true CA2620740A1 (en) | 2007-03-08 |
Family
ID=37607561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002620740A Abandoned CA2620740A1 (en) | 2005-09-01 | 2006-08-31 | Pyridazinone derivatives used for the treatment of pain |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090042856A1 (enExample) |
| EP (1) | EP1919919A1 (enExample) |
| JP (1) | JP5066516B2 (enExample) |
| KR (1) | KR20080049758A (enExample) |
| CN (1) | CN101268079B (enExample) |
| AU (1) | AU2006285599A1 (enExample) |
| BR (1) | BRPI0617100A2 (enExample) |
| CA (1) | CA2620740A1 (enExample) |
| IL (1) | IL189697A0 (enExample) |
| NO (1) | NO20081572L (enExample) |
| RU (1) | RU2008112290A (enExample) |
| TW (1) | TW200745034A (enExample) |
| WO (1) | WO2007026950A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200904421A (en) | 2007-05-03 | 2009-02-01 | Astellas Pharma Inc | New compounds |
| US8188083B2 (en) | 2007-06-28 | 2012-05-29 | Abbott Laboratories | Triazolopyridazines |
| JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン, インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
| KR101851418B1 (ko) * | 2010-09-08 | 2018-04-23 | 스미또모 가가꾸 가부시끼가이샤 | 피리다지논 화합물 및 그 중간체의 제조 방법 |
| BR112014008223A2 (pt) | 2011-10-06 | 2017-04-25 | Bayer Ip Gmbh | heterociclilpiri (mi) dinilpirazol |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| EA028756B1 (ru) | 2013-04-25 | 2017-12-29 | Бэйджин, Лтд. | Конденсированные гетероциклические соединения в качестве ингибиторов протеинкиназы |
| PT3702373T (pt) | 2013-09-13 | 2022-09-27 | Beigene Switzerland Gmbh | Anticorpos anti-pd1 e a sua utilização como agentes terapêuticos e de diagnóstico |
| MX382781B (es) | 2014-04-02 | 2025-03-13 | Intermune Inc | Piridinonas anti-fibroticas. |
| JP6526189B2 (ja) | 2014-07-03 | 2019-06-05 | ベイジーン リミテッド | 抗pd−l1抗体並びにその治療及び診断のための使用 |
| CN111153859B (zh) * | 2015-04-15 | 2021-09-03 | 江苏恩华药业股份有限公司 | 哒嗪酮类衍生物及其应用 |
| CN109475536B (zh) | 2016-07-05 | 2022-05-27 | 百济神州有限公司 | 用于治疗癌症的PD-l拮抗剂和RAF抑制剂的组合 |
| SG11201901141WA (en) | 2016-08-16 | 2019-03-28 | Beigene Ltd | Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof |
| CN118252927A (zh) | 2016-08-19 | 2024-06-28 | 百济神州有限公司 | 使用包含btk抑制剂的组合产品治疗癌症 |
| MA46092A (fr) | 2016-08-31 | 2021-04-21 | Agios Pharmaceuticals Inc | Inhibiteurs de processus métaboliques cellulaires |
| EP3558363A1 (en) | 2016-12-21 | 2019-10-30 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| WO2018137681A1 (en) | 2017-01-25 | 2018-08-02 | Beigene, Ltd. | Crystalline forms of (s) -7- (1- (but-2-ynoyl) piperidin-4-yl) -2- (4-phenoxyphenyl) -4, 5, 6, 7-tetrahy dropyrazolo [1, 5-a] pyrimidine-3-carboxamide, preparation, and uses thereof |
| TW202332436A (zh) * | 2017-04-18 | 2023-08-16 | 美商塞爾基因定量細胞研究公司 | 治療用化合物 |
| JP2020525411A (ja) | 2017-06-26 | 2020-08-27 | ベイジーン リミテッド | 肝細胞癌のための免疫療法 |
| WO2019034009A1 (en) | 2017-08-12 | 2019-02-21 | Beigene, Ltd. | BTK INHIBITOR WITH ENHANCED DOUBLE SELECTIVITY |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| PT3691620T (pt) | 2017-10-05 | 2022-10-06 | Fulcrum Therapeutics Inc | Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd |
| WO2019108795A1 (en) | 2017-11-29 | 2019-06-06 | Beigene Switzerland Gmbh | Treatment of indolent or aggressive b-cell lymphomas using a combination comprising btk inhibitors |
| US20220249491A1 (en) | 2019-06-10 | 2022-08-11 | Beigene Switzerland Gmbh | Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor |
| TW202112368A (zh) | 2019-06-13 | 2021-04-01 | 荷蘭商法西歐知識產權股份有限公司 | 用於治療有關dux4表現之疾病的抑制劑組合 |
| US11786531B1 (en) | 2022-06-08 | 2023-10-17 | Beigene Switzerland Gmbh | Methods of treating B-cell proliferative disorder |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356897A (en) * | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
| US20040152659A1 (en) * | 1999-05-12 | 2004-08-05 | Fujisawa Pharmaceutical Co. Ltd. | Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist |
| AU4431000A (en) * | 1999-05-12 | 2000-12-05 | Fujisawa Pharmaceutical Co., Ltd. | Novel use |
| AUPQ441499A0 (en) * | 1999-12-02 | 2000-01-06 | Fujisawa Pharmaceutical Co., Ltd. | Novel compound |
| WO2006038734A1 (en) * | 2004-10-08 | 2006-04-13 | Astellas Pharma Inc. | Pyridazinone derivatives cytokines inhibitors |
-
2006
- 2006-08-31 BR BRPI0617100-1A patent/BRPI0617100A2/pt not_active IP Right Cessation
- 2006-08-31 KR KR1020087007056A patent/KR20080049758A/ko not_active Ceased
- 2006-08-31 RU RU2008112290/04A patent/RU2008112290A/ru not_active Application Discontinuation
- 2006-08-31 AU AU2006285599A patent/AU2006285599A1/en not_active Abandoned
- 2006-08-31 JP JP2008511498A patent/JP5066516B2/ja not_active Expired - Fee Related
- 2006-08-31 EP EP06797567A patent/EP1919919A1/en not_active Withdrawn
- 2006-08-31 CA CA002620740A patent/CA2620740A1/en not_active Abandoned
- 2006-08-31 TW TW095132103A patent/TW200745034A/zh unknown
- 2006-08-31 WO PCT/JP2006/317691 patent/WO2007026950A1/en not_active Ceased
- 2006-08-31 US US12/063,766 patent/US20090042856A1/en not_active Abandoned
- 2006-08-31 CN CN2006800322174A patent/CN101268079B/zh not_active Expired - Fee Related
-
2008
- 2008-02-24 IL IL189697A patent/IL189697A0/en unknown
- 2008-03-31 NO NO20081572A patent/NO20081572L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0617100A2 (pt) | 2011-07-12 |
| IL189697A0 (en) | 2008-06-05 |
| TW200745034A (en) | 2007-12-16 |
| NO20081572L (no) | 2008-03-31 |
| CN101268079B (zh) | 2011-09-14 |
| RU2008112290A (ru) | 2009-10-10 |
| JP5066516B2 (ja) | 2012-11-07 |
| AU2006285599A1 (en) | 2007-03-08 |
| EP1919919A1 (en) | 2008-05-14 |
| KR20080049758A (ko) | 2008-06-04 |
| JP2009507758A (ja) | 2009-02-26 |
| US20090042856A1 (en) | 2009-02-12 |
| CN101268079A (zh) | 2008-09-17 |
| WO2007026950A1 (en) | 2007-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5066516B2 (ja) | 疼痛の治療に用いられるピリダジノン誘導体 | |
| CA2932425E (en) | Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides | |
| US7834019B2 (en) | Substituted pyrazolo[3,4-d]pyrimidinone derivatives | |
| CA2677572C (en) | 3-amino-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives as pkc inhibitors | |
| US20120095005A1 (en) | Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors | |
| JP5116687B2 (ja) | がんおよび他の過剰増殖性疾患の処置のためのピロロ[2,1−f][1,2,4]トリアジン−4−イルアミンIGF−1Rキナーゼ阻害剤 | |
| US9981976B2 (en) | Piperidine substituted pyrazolo[1,5-A]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV) | |
| US8658794B2 (en) | 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof | |
| ES2654288T3 (es) | Moduladores de P2X7 | |
| TW202344505A (zh) | 作為parp7抑制劑的嗒𠯤酮 | |
| CA2953798A1 (en) | Aminopyridazinone compounds as protein kinase inhibitors | |
| SK3842001A3 (en) | Pyrrolopyrimidines as protein kinase inhibitors (revised) | |
| CN112584898B (zh) | P2x3受体拮抗剂 | |
| KR20220163955A (ko) | 보체 억제제로서의 피롤로피리미딘 아민 | |
| WO2016045598A1 (zh) | 4-取代吡咯并[2,3-d]嘧啶化合物及其用途 | |
| JP2024544794A (ja) | (s)-2-(2-メチルアゼチジン-1-イル)ピリミジン誘導体およびそれを含む医薬組成物 | |
| HK1124603A (en) | Pyridazinone derivatives used for the treatment of pain | |
| NZ624021B2 (en) | Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20140604 |